First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - OUR HEALTH PHARMA INVESTMENTS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: OUR HEALTH PHARMA INVESTMENTS LIMITED, 71 ANEURIN WAY, SKETTY, SWANSEA, SA2 8NP. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2023. The company was incorporated on 30 March 2021.

The accounts next due date is 31 December 2024. There are 2 mortgages, none satisfied, none part satisfied and 2 unsatisfied.

The above was based on public record information as at 8 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13304049
Date Incorporated: 30 March 2021
Date Latest Accounts: 31 March 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13304049
Annual Return: Unknown
Registered Office: 71 ANEURIN WAY, SKETTY, SWANSEA, SA2 8NP
SIC Code and Operations: 68100,68201,68209,68320
SECURED CREDITORS
Number of Mortgages 2
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 2
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

OUR HEALTH PHARMA INVESTMENTS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 18 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12045076 OUR HEALTH PHARMA LIMITED Active
08186150 OUR HEALTH SPACE LIMITED Dissolved
06773473 OUR HEALTH UK LTD Active
10880643 OUR HEALTHY FUTURE LTD Active
07857623 OUR HEALTHY WORLD LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd